Clinical landscape for patients with head and neck cancers enrolled in phase I trials at a tertiary referral center.
Saved in:
| Title: | Clinical landscape for patients with head and neck cancers enrolled in phase I trials at a tertiary referral center. |
|---|---|
| Authors: | Filippini DM; Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Sant' Orsola-Malpighi Hospital, Pietro Albertoni Street, Bologna I-40138, Italy., Sanchez R; Department of Drug Development and Innovation (D3i), Institut Curie, Paris, France., Bastien E; Department of Drug Development and Innovation (D3i), Institut Curie, Paris, France., Jacquin N; Department of Drug Development and Innovation (D3i), Institut Curie, Paris, France., Paccapelo A; Research and Innovation Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy., Nhy C; Radiology Department, Institut Curie Hospital, Paris, France., Klijanienko J; Department of Pathology, Institut Curie, PSL Research University, Paris, France., Calugaru V; Department of Radiation Oncology, Institut Curie, Paris, France., Chilles A; Department of Radiation Oncology, Institut Curie, Paris, France., Ghanem W; Department of Head and Neck Surgery, Institut Curie, Paris, France., Rougier G; Department of Head and Neck Surgery, Institut Curie, Paris, France., Dubray Vautrin A; Department of Head and Neck Surgery, Institut Curie, Paris, France., Badois N; Department of Head and Neck Surgery, Institut Curie, Paris, France., Lesnik M; Department of Head and Neck Surgery, Institut Curie, Paris, France., Choussy O; Department of Head and Neck Surgery, Institut Curie, Paris, France., Sablin MP; Department of Drug Development and Innovation (D3i), Institut Curie, Paris, France., Le Tourneau C; Department of Drug Development and Innovation (D3i), Institut Curie, Paris, France.; INSERM U900 Research Unit, Saint-Cloud, France.; Paris-Saclay University, Paris, France., Marret G; Department of Drug Development and Innovation (D3i), Institut Curie, Paris, France. |
| Source: | Therapeutic advances in medical oncology [Ther Adv Med Oncol] 2025 Jun 30; Vol. 17, pp. 17588359251337244. Date of Electronic Publication: 2025 Jun 30 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Sage Country of Publication: England NLM ID: 101510808 Publication Model: eCollection Cited Medium: Print ISSN: 1758-8340 (Print) Linking ISSN: 17588340 NLM ISO Abbreviation: Ther Adv Med Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1758-8340 |
|---|---|
| DOI: | 10.1177/17588359251337244 |
